HAYWARD, Calif., Oct. 25 /PRNewswire-FirstCall/ -- Kosan Biosciences Inc. (Nasdaq: KOSN) today announced that it will host a Research and Development Day on Wednesday, October 31, 2007, beginning at approximately 7:30 a.m. Eastern Time (4:30 a.m. Pacific Time). In addition to presentations by Kosan's Executives, Robert G. Johnson, Jr., M.D., Ph.D., President and Chief Executive Officer and Pieter Timmermans, Ph.D., Senior Vice President, Drug Discovery and Preclinical Development, invited guest speakers include key oncology opinion leaders.
-- Kenneth C. Anderson, M.D., Kraft Family Professor of Medicine at
Harvard Medical School, Chief of the Division of Hematologic Neoplasia,
Director of the Jerome Lipper Multiple Myeloma Center, and Vice Chair
of the Joint Program in Transfusion Medicine at Dana-Farber Cancer
-- Howard (Skip) A. Burris III, M.D., F.A.C.P., Chief Medical Officer and
Director, Drug Development at Sarah Cannon Research Institute
-- Clifford A. Hudis, M.D., Chief of the Breast Cancer Medicine Service
and Attending Physician at Memorial Sloan-Kettering Cancer Center and
Associate Professor of Medicine at Weill Medical College of Cornell
-- Neal Rosen, M.D, Ph.D., Enid A. Haupt Chair in Medical Oncology,
Member, Department of Medicine and Program in Molecular Pharmacology
and Chemistry, Head, Developmental Therapeutics at Memorial
Sloan-Kettering Cancer Center
A live audio webcast of the presentation will be available at
http://www.kosan.com on the "Investors/Press" page under "Upcoming Events"
or by clicking
|SOURCE Kosan Biosciences Inc.|
Copyright©2007 PR Newswire.
All rights reserved